Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 92 results found. Search for [ AIIMS cOVID-19 vaccine news ]

Results 1 to 21 of 92
PTI
February 20, 2021
Speaking at an AIMA event here, Guleria said the vaccine is the only weapon available to gain immunity and help reduce mortality rate due to the infectious disease


BusinessToday.In
New Delhi, February 18, 2021
PM Modi calls for lower import dependence as petrol prices touch Rs 100; COVID-19 vaccine likely to be available in open market after 'prime targets' covered, says Randeep Guleria, AIIMS Director; South African variant could significantly reduce vaccine protection, says Pfizer. Watch this and more news on News Blast.


BusinessToday.In
February 17, 2021
Saying that vaccination is necessary to fight the pandemic, Guleria urged people to not be afraid of the vaccine as it is totally safe.


BusinessToday.In
January 19, 2021
According to experts, people have adopted a \"wait and watch\" approach which has resulted in low turnout at vaccination centres


BusinessToday.In
January 19, 2021
COVID-19 immunisation in Delhi: The sharp drop in immunisations comes after 51 adverse events following immunization - one severe and 50 minor cases were reported from Delhi on Saturday


BusinessToday.In
January 16, 2021
A total of 16,755 vaccinators participated in the vaccination process across India, the ministry added. Not a single case of hospitalisation post-vaccine administration has been reported yet


BusinessToday.In
January 16, 2021
In the first phase of the vaccination drive over 3 crores frontline healthcare workers are expected to be given the vaccine. They will receive either Covaxin or Covishield COVID-19 vaccines which were approved for emergency use earlier by the country's drug regulators


BusinessToday.In
January 16, 2021
In the consent form for getting Covaxin vaccine, recipients have been promised that in case of any adverse situation following the administration of the vaccine and if it is determined that the vaccine was the cause then the recipients will be given compensation and medical


BusinessToday.In
January 16, 2021
PM Modi launches COVID-19 vaccination drive: Urging people to take the vaccine and to take the complete course PM Modi allayed fears surrounding the jab. He said that when it comes to vaccines, India enjoys scientific credibility


BusinessToday.In
January 16, 2021
COVID-19 vaccination drive India: Dr Guleria was the third person to take the shot. Before him, a sanitation worker and a healthcare worker got vaccinated


PTI
January 14, 2021
This will be the world's largest vaccination programme covering the entire length and breadth of the country and all preparations are in place to initiate the programme on the principles of 'Jan Bhagidari', the Prime Minister's Office said in a statement


BusinessToday.In
New Delhi, January 7, 2021
Dr Randeep Guleria, Director, AIIMS, in an interview with India Today TV talks about the plan for vaccination in India. Healthcare and frontline workers, the aged and people with comorbidities would be given priority. Dr Guleria explains.Also Read: 10% COVID-19 vaccines will be wasted, says Centre; to cost Rs 1,320 crore more


BusinessToday.In
January 3, 2021
The ICMR head emphasised that the scientists at ICMR have been successfully able to culture the UK strain and the efficacy of Covaxin against it will be further tested in days to come


BusinessToday.In
January 3, 2021
Calling it a great day for the country, AIIMS Director Dr Randeep Guleria said that initially Serum-AstraZeneca's Covishield will be administered to the people


BusinessToday.In
December 7, 2020
On December 2, the UK became the first nation to approve Pfizer-BioNTech vaccine against COVID-19 for emergency use; Bahrain has also approved vaccine candidate 'BNT162b2'. India decision on vaccine could come this week


BusinessToday.In
December 6, 2020
Pfizer Inc submitted application to DCGI seeking emergency use authorisation on Dec 4; also seeks permission to import vaccine for sale and distribution in India


BusinessToday.In
December 5, 2020
Confirmation of approval by National Health Regulatory Authority of Bahrain followed thorough analysis and review undertaken by authority of all available data


BusinessToday.In
New Delhi, December 4, 2020
Pfizer pledges commitment to engage with Indian government for vaccine provision; Aviation industry to lose Rs 21,000 crore in FY21; Only Saffola, MarkfedSohna, Nature's Nectar among 13 brands pass sugar syrup test, claims CSE. Watch this and more news on News Blast.


Rashi Bisaria
New Delhi, December 4, 2020
Focus on higher spending, stronger growth in next Budget: FM Sitharaman India's economy will return to growth in 2021/22 and higher spending in the budget due in February will lay the foundations for even stronger growth in the next four to five years, Finance Minister Nirmala Sitharaman told Reuters on Thursday. With the world's second highest cases of coronavirus despite a severe lockdown of its 1.3 billion people early on in the pandemic, India's economy is expected to contract nearly 10...


BusinessToday.In
December 3, 2020
Speaking on COVID-19 vaccine and India's rollout plan, the AIIMS Director said that he is hopeful that by the end of December or early January, emergency use authorisation will be received from Indian regulatory authorities


PAGES 1 OF 5  12345